ARD-101
AVK-101-302
Phase 3 small_molecule on_hold
Quick answer
ARD-101 for Hyperphagia is a Phase 3 program (small_molecule) at Aardvark Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aardvark Therapeutics
- Indication
- Hyperphagia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- on_hold